PHILADELPHIA (Legal Newsline) - California Attorney General
Kamala Harris has announced that California, in conjunction with 34 other
states and the District of Columbia, has filed a lawsuit against Indivior, a British
pharmaceutical company, and MonoSol Rx for alleged
According to the lawsuit, the two companies created a
scheme. The purported scheme was designed to block competition for an opioid
addiction treatment called Suboxone. The states allege this unlawful plan
generated millions in undeserved profits for the companies.
"When prescription drug companies unlawfully manipulate
the marketplace to maximize profits, they put lives at risk and drive up the
cost of healthcare for everyone.
Indivior and Monosol flagrantly violated the law, deceiving doctors and
patients and shutting down generic competition in order to rake in
profits," Harris said. "These companies must be held accountable for
this unlawful scheme that cost the public nearly a billion dollars and hampered
fair competition in the marketplace."
According to the complaint, the product-hopping scheme is a
monopoly. The states charge the companies with conspiracy to monopolize, violations
of federal antitrust laws, and violations of the California’s
Cartwright Act and Unfair Competition Law.